HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Antonella Forlino Selected Research

Prolidase Deficiency

3/2015Lack of prolidase causes a bone phenotype both in human and in mouse.
1/2013Kinetic and structural evidences on human prolidase pathological mutants suggest strategies for enzyme functional rescue.
1/2012Partial Rescue of Biochemical Parameters After Hematopoietic Stem Cell Transplantation in a Patient with Prolidase Deficiency Due to Two Novel PEPD Mutations.
9/2011Improved prolidase activity assay allowed enzyme kinetic characterization and faster prolidase deficiency diagnosis.
5/2010Identifying the structure of the active sites of human recombinant prolidase.
12/2006Human recombinant prolidase from eukaryotic and prokaryotic sources. Expression, purification, characterization and long-term stability studies.
6/2005N-benzyloxycarbonyl-L-proline: an in vitro and in vivo inhibitor of prolidase.
9/2003Optimization of a capillary electrophoretic method to detect and quantify the Gly-Pro dipeptide in complex matrices from long term cultured prolidase deficiency fibroblasts.
10/2002Mutation analysis of five new patients affected by prolidase deficiency: the lack of enzyme activity causes necrosis-like cell death in cultured fibroblasts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Antonella Forlino Research Topics

Disease

9Prolidase Deficiency
03/2015 - 10/2002
9Osteogenesis Imperfecta (Lobstein Disease)
05/2014 - 05/2004
3Osteochondrodysplasias (Spondyloepiphyseal Dysplasia)
08/2012 - 03/2005
3Mental Retardation (Idiocy)
05/2010 - 10/2002
2Developmental Bone Diseases (Bone Dysplasia)
05/2014 - 07/2012
2Neoplasms (Cancer)
03/2014 - 12/2013
1Fanconi Anemia (Fanconi's Anemia)
05/2015
1Metabolic Bone Diseases (Osteopenia)
03/2015
1Microcephaly
03/2015
1Genu Valgum
03/2015
1Hypertelorism
03/2015
1Adenoma (Adenomas)
03/2014
1Hyperplasia
03/2014
1Cushing Syndrome
03/2014
1Shock
01/2013
1Dislocations
08/2012
1Congenital Abnormalities (Deformity)
07/2010
1Respiratory Tract Infections (Respiratory Tract Infection)
05/2010
1Platybasia (Basilar Impression)
01/2010
1Carcinoma (Carcinomatosis)
01/2008
1Breast Neoplasms (Breast Cancer)
01/2008
1Ichthyosis (Xeroderma)
05/2007
1Infection
12/2006
1Osteoporosis
03/2005
1Necrosis
10/2002

Drug/Important Bio-Agent (IBA)

8proline dipeptidase (prolidase)IBA
03/2015 - 10/2002
6Collagen Type I (Type I Collagen)IBA
05/2014 - 05/2004
6CollagenIBA
05/2014 - 05/2004
3Proteins (Proteins, Gene)IBA
01/2013 - 06/2007
2DiphosphonatesIBA
09/2011 - 01/2010
2Proteoglycans (Proteoglycan)IBA
01/2008 - 03/2007
2Diastrophic dysplasiaIBA
01/2006 - 03/2005
1VACTERL associationIBA
05/2015
1Mutant Proteins (Protein, Mutant)IBA
03/2015
1Hydrocortisone (Cortisol)FDA LinkGeneric
03/2014
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
03/2014
1Adrenocorticotropic Hormone (ACTH)FDA Link
03/2014
1Sodium-Hydrogen AntiporterIBA
12/2013
1ChondroitinIBA
08/2012
1HSP47 Heat-Shock Proteins (Heat Shock Protein 47)IBA
09/2011
1Human Growth Hormone (Saizen)FDA LinkGeneric
09/2011
1Chondroitin Sulfate ProteoglycansIBA
07/2010
1Growth Hormone (Somatotropin)IBA
01/2010
1Glycine (Aminoacetic Acid)FDA LinkGeneric
07/2009
1Biological Markers (Surrogate Marker)IBA
01/2008
1DecorinIBA
01/2008
1CholesterolIBA
05/2007
1lamin B receptorIBA
05/2007
1HEM dysplasiaIBA
05/2007
1IntegrinsIBA
03/2007
1DipeptidesIBA
06/2005
1Tolonium ChlorideFDA Link
03/2005
1glycylproline (Gly-Pro)IBA
09/2003

Therapy/Procedure

1Hematopoietic Stem Cell Transplantation
01/2012
1Transplantation (Transplant Recipients)
07/2009